Shaji Daniel
About Shaji Daniel
Shaji Daniel is a Team Lead at the National Institutes of Health, specializing in molecular virology and immunology. He holds a Ph.D. from the Indian Institute of Science and has extensive experience in immune response analysis and antiviral drug development.
Current Role at National Institutes of Health
Shaji Daniel has been serving as a Team Lead at the National Institutes of Health (NIH) since 2013. In this role, he oversees various projects and initiatives related to immunology and virology. His position in Rockville, MD, allows him to contribute to significant research efforts aimed at understanding and combating viral infections.
Education and Expertise
Shaji Daniel holds a Doctor of Philosophy (Ph.D.) in Molecular Virology from the Indian Institute of Science, where he studied from 1993 to 1999. He also earned a Master of Science (MS) in Biotechnology from M. S. University of Baroda and a Bachelor of Science (B.S.) in Microbiology from the University of Bombay. His expertise includes PBMC isolation, purification of NKT cells, and advanced techniques in analyzing immune responses.
Professional Experience
Prior to his current role at NIH, Shaji Daniel worked in various research positions. He was a Research Associate at Cleveland Clinic from 2000 to 2006 and at Indiana University from 2007 to 2010. He also served as a Scientist at RetroVirox Inc. from 2011 to 2012. His diverse experience spans over two decades in the fields of molecular virology and immunology.
Research Contributions
Shaji Daniel has co-authored three publications in prominent journals within the fields of immunology and virology. His research contributions include extensive work in antiviral drug development under GLP conditions and the development of malaria vaccines utilizing various platforms such as DNA and recombinant adenovirus.
Technical Skills and Techniques
Shaji Daniel possesses a strong background in advanced laboratory techniques, including multi-parameter flow cytometry and CD8 T cell depletion studies. His skills in cell-based assays and flow cytometry have been instrumental in his research on antigen-specific immune responses and antiviral strategies.